Literature DB >> 19526482

Transcription factor Nfat1 deficiency causes osteoarthritis through dysfunction of adult articular chondrocytes.

Jinxi Wang1, Brian M Gardner, Qinghua Lu, Marianna Rodova, Brent G Woodbury, John G Yost, Katherine F Roby, David M Pinson, Ossama Tawfik, Harrison C Anderson.   

Abstract

Osteoarthritis (OA) is the most common form of joint disease in middle-aged and older individuals. Previous studies have shown that over-expression of matrix-degrading proteinases and proinflammatory cytokines is associated with osteoarthritic cartilage degradation. However, it remains unclear which transcription factors regulate the expression of these cartilage-degrading molecules in articular chondrocytes. This study demonstrated that mice lacking Nfat1, a member of the nuclear factor of activated T cells (NFAT) transcription factors, exhibited normal skeletal development but displayed loss of type II collagen (collagen-2) and aggrecan with over-expression of specific matrix-degrading proteinases and proinflammatory cytokines in young adult articular cartilage of load-bearing joints. These initial changes are followed by articular chondrocyte proliferation/clustering, progressive articular surface destruction, periarticular chondro-osteophyte formation and exposure of thickened subchondral bone, all of which resemble human OA. Forced expression of Nfat1 delivered with lentiviral vectors in cultured 3 month-old primary Nfat1 knockout (Nfat1(-/-)) articular chondrocytes partially or completely rescued the abnormal catabolic and anabolic activities of Nfat1(-/-) articular chondrocytes. These new findings revealed a previously unrecognized critical role of Nfat1 in maintaining the physiological function of differentiated adult articular chondrocytes through regulating the expression of specific matrix-degrading proteinases and proinflammatory cytokines. Nfat1 deficiency causes OA due to an imbalance between the catabolic and anabolic activities of adult articular chondrocytes, leading to articular cartilage degradation and failed repair activities in and around articular cartilage. These results may provide new insights into the aetiology, pathogenesis and potential therapeutic strategies for osteoarthritis. 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19526482      PMCID: PMC2975457          DOI: 10.1002/path.2578

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The importance of subchondral bone in the progression of osteoarthritis.

Authors:  David B Burr
Journal:  J Rheumatol Suppl       Date:  2004-04

3.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

4.  Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage.

Authors:  T Kirsch; B Swoboda; H Nah
Journal:  Osteoarthritis Cartilage       Date:  2000-07       Impact factor: 6.576

5.  Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints.

Authors:  Z Mi; S C Ghivizzani; E R Lechman; D Jaffurs; J C Glorioso; C H Evans; P D Robbins
Journal:  Arthritis Rheum       Date:  2000-11

6.  Calcineurin and NFAT4 induce chondrogenesis.

Authors:  Masuhiro Tomita; Martina I Reinhold; Jeffery D Molkentin; Michael C Naski
Journal:  J Biol Chem       Date:  2002-09-17       Impact factor: 5.157

7.  SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes.

Authors:  Thomas Aigner; Pia Margarethe Gebhard; Erik Schmid; Brigitte Bau; Vincent Harley; Ernst Pöschl
Journal:  Matrix Biol       Date:  2003-06       Impact factor: 11.583

8.  Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis.

Authors:  Alwin Scharstuhl; Elly L Vitters; Peter M van der Kraan; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2003-12

9.  Mutation analyses of the NFAT1 gene in chondrosarcomas and enchondromas.

Authors:  Tomoki Aoyama; Satoshi Nagayama; Takeshi Okamoto; Taisuke Hosaka; Takeharu Nakamata; Koichi Nishijo; Tadao Tsuboyama; Tomitaka Nakayama; Takashi Nakamura; Junya Toguchida
Journal:  Cancer Lett       Date:  2002-12-01       Impact factor: 8.679

10.  The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis.

Authors:  A M Ranger; L C Gerstenfeld; J Wang; T Kon; H Bae; E M Gravallese; M J Glimcher; L H Glimcher
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

View more
  45 in total

Review 1.  Transcriptional network systems in cartilage development and disease.

Authors:  Riko Nishimura; Kenji Hata; Eriko Nakamura; Tomohiko Murakami; Yoshifumi Takahata
Journal:  Histochem Cell Biol       Date:  2018-01-08       Impact factor: 4.304

2.  Epigenetically mediated spontaneous reduction of NFAT1 expression causes imbalanced metabolic activities of articular chondrocytes in aged mice.

Authors:  M Zhang; Q Lu; B Egan; X-B Zhong; K Brandt; J Wang
Journal:  Osteoarthritis Cartilage       Date:  2016-02-20       Impact factor: 6.576

3.  NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Gunjan D Manocha; Atreyi Ghatak; Kendra L Puig; Susan D Kraner; Christopher M Norris; Colin K Combs
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Epigenetic mechanisms underlying the aberrant catabolic and anabolic activities of osteoarthritic chondrocytes.

Authors:  Mingcai Zhang; Brian Egan; Jinxi Wang
Journal:  Int J Biochem Cell Biol       Date:  2015-05-12       Impact factor: 5.085

5.  An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis.

Authors:  Marian Seda; Maartje Geerlings; Peggy Lim; Jeshmi Jeyabalan-Srikaran; Ann-Christin Cichon; Peter J Scambler; Philip L Beales; Victor Hernandez-Hernandez; Andrew W Stoker; Dagan Jenkins
Journal:  Mol Syndromol       Date:  2018-07-21

6.  Nfatc2 is a primary response gene of Nell-1 regulating chondrogenesis in ATDC5 cells.

Authors:  Weiwei Chen; Xinli Zhang; Ronald K Siu; Feng Chen; Jia Shen; Janette N Zara; Cymbeline T Culiat; Sotirios Tetradis; Kang Ting; Chia Soo
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

7.  Identification of Differentially Expressed Genes under the Regulation of Transcription Factors in Osteosarcoma.

Authors:  Yang Liu; Jianzhong Guan; Xiaotian Chen
Journal:  Pathol Oncol Res       Date:  2018-11-08       Impact factor: 3.201

8.  Distinct Transcriptional Programs Underlie Sox9 Regulation of the Mammalian Chondrocyte.

Authors:  Shinsuke Ohba; Xinjun He; Hironori Hojo; Andrew P McMahon
Journal:  Cell Rep       Date:  2015-07-02       Impact factor: 9.423

Review 9.  Cell-based articular cartilage repair: the link between development and regeneration.

Authors:  K L Caldwell; J Wang
Journal:  Osteoarthritis Cartilage       Date:  2014-11-11       Impact factor: 6.576

10.  The chondrocyte clock gene Bmal1 controls cartilage homeostasis and integrity.

Authors:  Michal Dudek; Nicole Gossan; Nan Yang; Hee-Jeong Im; Jayalath P D Ruckshanthi; Hikari Yoshitane; Xin Li; Ding Jin; Ping Wang; Maya Boudiffa; Ilaria Bellantuono; Yoshitaka Fukada; Ray P Boot-Handford; Qing-Jun Meng
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.